Pharmaceutical Regulatory Affairs Market

Pharmaceutical Regulatory Affairs, or Pharma Regulatory Affairs, refers to the professionals who maintain regulations from within the industry. The pharmaceutical industry is the most regulated of all industries. Regulatory affairs professionals are key, but perhaps overlooked, players in drug development. They are the primary communications link between the company and agencies such as FDA, and they are responsible for keeping up with the increasing scope and complexity of regulations. In the pharmaceutical industry, regulatory affairs professionals have expertise in the legal and regulatory environments, as well as in clinical research protocols.

Pharmaceutical Regulatory Affairs Market contains market size and forecasts of Pharmaceutical Regulatory Affairs in Global, including the following market information:

Global Pharmaceutical Regulatory Affairs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Pharmaceutical Regulatory Affairs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Regulatory Consulting Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Pharmaceutical Regulatory Affairs include QuintilesIMS, LabCor, PAREXEL, Pharmaceutical Product Development, INC RESEARCH HOLDINGS, PRA Health Sciences, ICON, Charles River and Advent International, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Pharmaceutical Regulatory Affairs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Pharmaceutical Regulatory Affairs Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Pharmaceutical Regulatory Affairs Market Segment Percentages, by Type, 2021 (%)

Regulatory Consulting

Legal Representation

Regulatory Writing & Publishing

Product Registration & Clinical Trial Application

Other Services

Global Pharmaceutical Regulatory Affairs Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Pharmaceutical Regulatory Affairs Market Segment Percentages, by Application, 2021 (%)

In-house

Outsourcing

Global Pharmaceutical Regulatory Affairs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Pharmaceutical Regulatory Affairs Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Pharmaceutical Regulatory Affairs revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Pharmaceutical Regulatory Affairs revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

QuintilesIMS

LabCor

PAREXEL

Pharmaceutical Product Development

INC RESEARCH HOLDINGS

PRA Health Sciences

ICON

Charles River

Advent International

WuXi AppTec, Inc.

Pharmaron Beijing Co., Ltd.

Hangzhou Tigermed Consulting Co.,Ltd.

Asymchem Laboratories (Tianjin) Co.,Ltd.

Accell Clinical Research, LLC.

GenPact Ltd.

Criterium, Inc.

Promedica International

Medpace

Covance

Freyr